This bidirectional regulation, rather than simple enhancement or inhibition, may explain BPC-157's apparent ability to promote healing in diverse pathological conditions
The compound belongs to a class of heterocyclic quinolinium derivatives investigated for their interaction with biochemical regulatory enzymes and metabolic signalling systems
Quality depends heavily on the compounding pharmacy
Potential side effects include: Injection site reactions, including redness, swelling, bruising, pain, or irritation Mild fluid retention (edema) Joint or muscle discomfort Headache, dizziness, or flushing Changes in glucose regulation, particularly in individuals with diabetes or prediabetes Itching, restlessness, drowsiness, nausea, or difficulty swallowing (3) Importantly, the occurrence of potential side effects does not predict an individual's overall response to therapy